Testing a new drug for moderate to severe sleep apnea
Part of Brain & nervous system, Lungs & breathing clinical trials.
This trial tests a drug called DAW2020 to see if it can improve how your body controls breathing during sleep. You may qualify if you have moderate to severe sleep apnea and are otherwise healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe sleep apnea (AHI of 15 or higher per hour).
- You are generally healthy with no major organ diseases.
- You do not take medications that affect breathing (like opioids or certain asthma drugs) or antidepressants (SNRIs/SSRIs).
- You do not have other sleep disorders like restless legs, narcolepsy, or sleepwalking.
- You are not allergic or have a known sensitivity to the study drug (DAW2020).
- You do not have low potassium, low magnesium, or uncontrolled thyroid disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares three treatments for obstructive sleep apnea: a CPAP machine, a dental mouthpiece, and a combination of two medications (atomoxetine and oxybutynin). Researchers want to see which works best for people recently diagnosed with sleep apnea.
This study tests whether atomoxetine and DAW2022 can improve how severe obstructive sleep apnea is. It may help by changing breathing patterns during sleep, measured through physiology tests.
This trial tests whether the medication trazodone can help people with moderate to severe obstructive sleep apnea (OSA). If you have OSA and are not taking certain medications or have other sleep disorders, you may be able to join.
This early study tests a medicine that is meant to improve how your brain and breathing muscles work during sleep for obstructive sleep apnea (OSA). If you qualify, you would be monitored during sleep to see whether the treatment changes breathing events and oxygen levels.
This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.
This trial tests whether combining electrical stimulation (via an Inspire device you already have or will get) with two medications can better treat obstructive sleep apnea. You'll help researchers understand if this combination works better than the device alone.
Hear when a new Obstructive Sleep Apnea (OSA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.